three60

three60, an annual review published by TomoTherapy, covers clinical advances in cancer treatment, cancer survivor stories and the latest innovations to our unique radiotherapy platform.

IN THE CURRENT ISSUE

three60, volume 2, features 10 ways Tomo^® technology is being used to advance cancer care around the world:

• Pursuing New Opportunities - Colleagues from Addenbrooke’s Hospital (Cambridge, U.K.) discuss how TomoTherapy^® technology opens new doors.
• Answering Patient Demand - Precisely targeting liver cancer and more, Yonsei University meets the needs of patients in Seoul, and throughout Korea.
• Increasing Departmental Efficiency - Azienda Ospedaliero, Modena, Italy, sees significant throughput gains after shifting complex cases to the Tomo platform.
• Embracing IMRT - Dr. Takeshi Kodaira of Aichi Cancer Center, Nagoya, Japan, discusses the adoption and application of an integrated solution for IG-IMRT.
• Maintaining Leadership - Executives from Reno, Nevada’s Renown Institute for Cancer shares the story of why they chose Tomo for the community.
• Improving Lung Cancer Care - Peter Hoban, Ph.D., of TomoTherapy, discusses how the good science behind TomoTherapy lung cancer treatments is paying clinical dividends.
• Streamlining Machine QA - Cliniques universitaires Saint-Luc, Catholic University (Brussels, Belgium) reports on a six-month evaluation of the TQA^™ integrated machine quality assurance application from TomoTherapy.
• Enhancing Workflow - TomoTherapy reports on how the OIS Connect^™ software option will enhance Tomo platform departmental integration and workflow.
• Easing Access to Cutting-Edge Care - An introduction to TomoMobile^™, the industry’s first relocatable radiotherapy solution
• Building on the Platform - An introduction to the TomoHD^™ treatment system, built on experience and built for the future

Access the digital edition or request a printed copy by e-mail, noting your name, affiliation and mailing address.